Diabetes drug Ozempic can reduce severe liver disease risk too

IANS | January 24, 2024 11:48 AM

London, Jan 24 (IANS) Novo Nordisk's Ozempic and other GLP1 agonists -- popular diabetes drugs -- are also associated with a reduced risk of developing cirrhosis and liver cancer in people with Type 2 diabetes and chronic liver disease, according to a study.

MP researchers’ incisionless device to boost treatment for diabetes, obesity

IANS | January 22, 2024 1:40 PM

New Delhi, Jan 22 (IANS) A team of an international team of researchers, led by those from India’s Madhya Pradesh, has developed a completely incisionless device that replicates metabolic surgery without making any cuts and could surpass current technologies for managing conditions such as severe obesity, Type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH).